secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avantor, Inc. (AVTR)
CIK:        0001722482
Form:       8-K
Filed at:   2023-12-07T23:59:59+00:00
Accession:  0001722482-23-000207
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avantor realigns into Laboratory Solutions and Bioscience Production; targets $300M in cost savings by 2026
--------------------------------------------------------------------------------

- New segments: Laboratory Solutions (~$4.7B revenue) and Bioscience Production (~$2.3B revenue), effective Q1 2024.
- Randy Stone named EVP Laboratory Solutions; Benoit Gourdier EVP Bioscience Production; Jim Bramwell EVP Sales, effective Jan 1, 2024.
- Sheri Lewis (EVP Global Supply Chain) and Frederic Vanderhaegen (EVP Europe) to depart in 2024 after transition.
- Cost optimization initiative targets $300M run-rate savings by end of 2026 through efficiency, footprint, and procurement.
- FY2023 guidance reaffirmed; two years of historical segment data to be provided in February 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1722482/000172248223000207/0001722482-23-000207-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1722482/000172248223000207/avtr-20231201.htm
  HTML page:      https://secwatch.observer/filing/0001722482-23-000207

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer